Breaking News
December 19, 2018 - FDA Approves Genentech’s Tecentriq in Combination With Avastin and Chemotherapy for the Initial Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer
December 19, 2018 - Mediterranean Diet for Osteoarthritis | About OA
December 19, 2018 - Successful bladder repair using silk fibroid scaffolds
December 19, 2018 - Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer
December 19, 2018 - Horizon Discovery partners with C4XD to validate novel synthetic lethal oncology targets
December 19, 2018 - Research suggests a promising therapeutic target to treat or prevent metabolic disorders
December 19, 2018 - Split liver transplants could save children on wait list finds study
December 19, 2018 - Michigan-based food manufacturer ordered to discontinue operations after recurrent food safety violations
December 19, 2018 - Incorrect prescribing warnings in electronic prescribing systems
December 19, 2018 - New $1.6 million NIH grant supports study on a gene vital to circadian rhythms
December 19, 2018 - Racial Disparities Seen Among Teens Undergoing Flu Vaccination
December 19, 2018 - To resolve inflammation, location matters
December 19, 2018 - Dancing could help older women to perform their daily tasks
December 19, 2018 - Research identifies new therapeutic target for cancer treatment and tissue regeneration
December 19, 2018 - Energy costs, social isolation contribute to health risk of older adults in extreme weather
December 19, 2018 - Potential combination therapy against rare disease of the bone marrow could improve treatment
December 19, 2018 - Researchers aim to improve cognition, reverse weight gain in schizophrenia
December 19, 2018 - UC San Diego Health offers new DRG stimulation device for phantom limb pain
December 19, 2018 - Study examines relationship between growth restriction and risk of childhood mortality
December 19, 2018 - New study provides insights on increased risk of suicide in young patients visiting ED
December 19, 2018 - AHA: Thyroid Problems Linked to Worsening Heart Failure
December 19, 2018 - World-first coeliac disease vaccine enters Phase 2 trials
December 19, 2018 - RNA sequencing offers novel insights into the microbiome
December 19, 2018 - A promising, effective vaccine for common respiratory disease
December 19, 2018 - Protein may slow progression of emphysema, study finds
December 19, 2018 - Studying atrial fibrillation — and exploring new frontiers in precision health
December 19, 2018 - A New Way To Get College Students Through A Psychiatric Crisis — And Back To School
December 19, 2018 - Optum, UnitedHealthcare take action to help people affected by North Carolina winter storms
December 18, 2018 - Weight change in middle-aged, elderly Chinese Singaporeans related to increased risk of death
December 18, 2018 - Immune cells sacrifice themselves to protect us from invading bacteria
December 18, 2018 - Watching brain cells fire, with a twist of gravitational waves
December 18, 2018 - 2018 in Review
December 18, 2018 - Getting the Most Out of the CLARITY Technique
December 18, 2018 - NVF shoes provide a viable option for track and road racing
December 18, 2018 - CRISPR may restore effectiveness of chemotherapies used to treat lung cancer
December 18, 2018 - New app accurately measures and charts progression of skin wounds
December 18, 2018 - Persistent Discrimination ID’d Among Physician Mothers
December 18, 2018 - Cellphone technology developed to detect HIV
December 18, 2018 - A Stanford doctor hits the field with the 49ers — as their airway management physician
December 18, 2018 - The Rise of Anxiety Baking
December 18, 2018 - Just one night of sleep deprivation increases the urge to eat
December 18, 2018 - Study reveals mechanism behind failed remyelination in MS
December 18, 2018 - New genetic testing method increases the precision of biomarker analysis
December 18, 2018 - Simple technique to effectively treat underdiagnosed cause of debilitating chest pain
December 18, 2018 - Barbershop-based medical intervention can successfully lower blood pressure, new data shows
December 18, 2018 - Food labels have caused changes in consumers’ intake and industry’s use of key additives
December 18, 2018 - Sickest children could benefit from split liver transplants
December 18, 2018 - Scientists create patient-specific model to identify most effective treatment for appendix cancer
December 18, 2018 - ‘Little Foot’ endocast reveals a small brain combining ape-like and human-like features
December 18, 2018 - New therapy for childhood blindness shows ‘very promising’ results
December 18, 2018 - Researchers discover promising new compound against Buruli ulcer
December 18, 2018 - Study finds significant use of traditional, complementary and alternative medicines in Sub-Saharan Africa
December 18, 2018 - California Farm Implicated in Outbreak of E. coli Tied to Romaine Lettuce
December 18, 2018 - Mobile health has power to transform HIV/AIDS nursing
December 18, 2018 - Celiac Vaccine in Clinical Trials at Columbia
December 18, 2018 - Research into mental health first aid prompts practical guidance and resources for workplace
December 18, 2018 - Researcher conducts study to investigate peripheral blood markers of Alzheimer’s disease
December 18, 2018 - Researchers identify link between mucus in the small airways and pulmonary fibrosis
December 18, 2018 - EU Commission’s Health Policy Platform to host EKHA program on transplantation
December 18, 2018 - Survivors of childhood Hodgkin lymphoma have high risk of developing solid tumors
December 18, 2018 - Small changes to cafeteria design can get kids to eat healthier, new assessment tool finds
December 18, 2018 - From Machines to Cyclic Compounds
December 18, 2018 - New study reveals best assessment tools to establish delirium severity
December 18, 2018 - Rice University scientists develop synthetic protein switches to control electron flow
December 18, 2018 - Home-based pulmonary function monitoring for teens with Duchenne muscular dystrophy
December 18, 2018 - Researchers identify potential target for new breast cancer treatments
December 18, 2018 - National Biofilms Innovation Centre award grant to Neem Biotech for novel anti-biofilm drug development
December 18, 2018 - Artificial intelligence and the future of medicine
December 18, 2018 - Montana State doctoral student receives grant for her work to improve neuroscience tool
December 18, 2018 - Early postpartum initiation of opioids associated with persistent use
December 18, 2018 - Russian scientists identify molecular ‘switch’ that could be target for treatment of allergic asthma
December 18, 2018 - Surgeons make more mistakes in the operating room during stressful moments, shows study
December 18, 2018 - Immune cells explode themselves to inform about the danger of invading bacteria
December 18, 2018 - Malnutrition in children with Crohn’s disease linked with increased risk of surgical complications
December 18, 2018 - FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC)
December 18, 2018 - The long and short of CDK12
December 18, 2018 - Hologic’s Cynosure division introduces TempSure Surgical RF technology in North America
December 18, 2018 - CMR Surgical partners with Nicholson Center to launch U.S.-based training program for Versius
December 18, 2018 - Findings reinforce guidelines for cautious use of antipsychotics in younger populations
December 18, 2018 - Study finds new strains of hepatitis C virus in sub-Saharan Africa
Specific way of spelling out genetic code likely allows viruses to evade our cellular defenses

Specific way of spelling out genetic code likely allows viruses to evade our cellular defenses

image_pdfDownload PDFimage_print

For millions of years, humans and viruses have engaged in a constant tug of war: as our cells evolve new ways to defend us from our viral enemies, these pathogens in turn acquire new traits to sidestep those defenses.

Now, scientists have found that a key similarity between our genes and those of many viruses–a way of spelling out the genetic code – has likely allowed viruses to evade our cellular defenses. Paul Bieniasz, a Rockefeller professor and Howard Hughes Medical Institute Investigator who led the work, says it began as an effort to understand how the viral genome affects the infectious potency of HIV, the virus that causes AIDS.

Reported in Nature, his lab’s recent findings offer insight into our cellular defense mechanisms, and suggest novel avenues for vaccine development.

Surprisingly enough, it all comes down to a matter of spelling.

There are a handful of words in the English language whose spellings can vary without changing their meaning: colour and color, for example, or traveler and traveller. Our genome is no different: there are many different ways of spelling the molecular code that makes up our genes without changing the proteins those genes produce. But Bieniasz and his colleagues found that for HIV and other viruses, certain spellings, or specific variants in the genetic code, are critical for viral replication and infection.

Two adjacent letters, lost in evolution

All genomes are strings of small molecules, known as bases, that are represented by letters such as C, G, and A. String those letters out in a particular order, and they spell a word, or gene, that produces a particular protein. In seeking to identify parts of the HIV genome that enable infection, the researchers generated mutant versions of the virus. But rather than changing the proteins spelled out through its genetic letters, they introduced alternate spellings for the genes, keeping the proteins unchanged.

The research team found that some of these viral mutants were unable to grow and replicate. “Intuitively, this is unexpected, because all of the proteins–the workhorses of the virus–are exactly the same,” Bieniasz explains.

The defective mutant viruses had one thing in common, however: they all contained multiple instances of a particular two-letter sequence: CG.

That two-letter sequence doesn’t seem like a terribly unlikely occurrence. There are just four letters in the genetic code, so the probability of finding any two letters together is high–1 in 16, to be exact. And yet, by an odd coincidence of evolution, the CG sequence is rare in human DNA. When placed side by side, the letter C can be modified in a chemical reaction that ultimately leads to its replacement by a different letter.

“Because of this evolutionary loss, the human genome now has about 80 percent fewer CG sequences than we would expect by chance,” explained graduate student Matthew A. Takata, lead author of the new paper.

A bull’s eye for the immune system

We humans are not alone in lacking CG sequences: normal HIV and many other viruses lack them too, but for different reasons. “Many viral genomes cannot go through the same chemical modification process that vertebrate genomes like our own have experienced,” Bieniasz said. “This led us to ask: How and why did HIV and other viruses lose their CG sequences?”

The researchers hypothesized that a cellular surveillance system might exist to identify and destroy CG sequences, thereby preventing viral infection. Bieniasz, Takata, and the research team exploited novel gene editing technology to search for proteins that might serve as such a defense mechanism. They found that in human cells, an antiviral protein called “ZAP” (Zinc-finger Antiviral Protein) can recognize molecules that have many CG sequences. ZAP binds to the sequences, identifying them as the mark of a foreign invader. These viral genomes are then destroyed.

The results offer insight into what caused HIV and other viruses to lose their CG sequences over time. These viruses have likely adapted to mammalian defense mechanisms, evolving to remove CG sequences and avoid surveillance by ZAP.

Although many animal viruses like HIV contain few CG sequences, and hence don’t get destroyed by ZAP, the researchers speculate that the protein still serves to protect us against other pathogens. “Its activity enables cells to recognize foreign invaders as ‘non-self,'” Bieniasz says, ” and may provide defense against viruses from other species, such as biting insects, whose genomes still have high numbers of CG sequences.”

Practically, the discovery may be useful in developing the weakened, or attenuated, viruses that are often used to make vaccines. By genetically engineering a virus to contain an increased number of CG sequences, researchers could potentially come up with a version that would prompt people’s immune systems to produce immunity against the pathogen without actually making them sick.

“Recoding a virus with many additional CG sequences,” says Takata, “is likely to be an effective, adjustable and largely irreversible way of attenuating it, making vaccine development faster and safer.”

Source:

https://www.rockefeller.edu/news/20795-in-the-fight-against-viral-infection-spelling-counts/

Tagged with:

About author

Related Articles